نتایج جستجو برای: HPV16 E6

تعداد نتایج: 6321  

2017
Y X Wang Y Z Li Z Y Zhang J Q Wang J Cui X L Qian

Background. Breast cancer remains the leading cause of cancer-related mortality worldwide. It has been indicated that human papillomaviruses 16 (HPV16) might participate in the pathogenesis and development of breast cancer. However, the detected rate of HPV16 varies with region. We will investigate HPV16 E6 expression in North China and explore the effects and mechanism of HPV16 E6 on breast ca...

2015
Christina Stutz Eileen Reinz Anja Honegger Julia Bulkescher Johannes Schweizer Katia Zanier Gilles Travé Claudia Lohrey Karin Hoppe-Seyler Felix Hoppe-Seyler Robert D. Burk

Oncogenic types of human papillomaviruses (HPVs) cause cervical cancer and other malignancies in humans. The HPV E6 oncoprotein is considered to be an attractive therapeutic target since its inhibition can lead to the apoptotic cell death of HPV-positive cancer cells. The HPV type 16 (HPV16) E6-binding peptide pep11, and variants thereof, induce cell death specifically in HPV16-positive cancer ...

Journal: :Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2015
Krystle A Lang Kuhs Devasena Anantharaman Tim Waterboer Mattias Johansson Paul Brennan Angelika Michel Martina Willhauck-Fleckenstein Mark P Purdue Ivana Holcátová Wolfgang Ahrens Pagona Lagiou Jerry Polesel Lorenzo Simonato Franco Merletti Claire M Healy Kristina Kjaerheim David I Conway Tatiana V Macfarlane Peter Thomson Xavier Castellsagué Ariana Znaor Amanda Black Wen-Yi Huang Vittorio Krogh Antonia Trichopoulou H B As Bueno-de-Mesquita Françoise Clavel-Chapelon Elisabete Weiderpass Johanna Ekström Elio Riboli Anne Tjønneland María-José Sánchez Ruth C Travis Allan Hildesheim Michael Pawlita Aimée R Kreimer

BACKGROUND The increasing incidence of oropharyngeal cancer in many developed countries has been attributed to human papillomavirus type 16 (HPV16) infections. Recently, HPV16 E6 serology has been identified as a promising early marker for oropharyngeal cancer. Therefore, characterization of HPV16 E6 seropositivity among individuals without cancer is warranted. METHODS A total of 4,666 contro...

Journal: :Cancer research 2007
Ya-Wen Cheng Ming-Fang Wu John Wang Kun-Tu Yeh Yih-Gang Goan Hui-Ling Chiou Chih-Yi Chen Huei Lee

Inactivation of p53 by human papillomavirus 16/18 E6 plays a crucial role in cervical tumorigenesis. To investigate the involvement of HPV16/18 in lung tumorigenesis, the association between HPV16 or HPV18 E6 and p53 protein expression in 122 lung tumors was evaluated by immunohistochemistry, and data showed that HPV16/18 E6 expression correlated inversely with p53 expression, which was further...

2017
Andrea Cerasuolo Clorinda Annunziata Marianna Tortora Noemy Starita Giovanni Stellato Stefano Greggi Maria Grazia Maglione Franco Ionna Simona Losito Gerardo Botti Luigi Buonaguro Franco M. Buonaguro Maria Lina Tornesello

Human papillomavirus type 16 (HPV16) is the major cause of cervical cancer and of a fraction of oropharyngeal carcinoma. Few studies compared the viral expression profiles in the two types of tumor. We analyzed HPV genotypes and viral load as well as early (E2/E4, E5, E6, E6*I, E6*II, E7) and late (L1 and L2) gene expression of HPV16 in cervical and oropharyngeal cancer biopsies. The study incl...

2014
Katia Zanier Christina Stutz Susanne Kintscher Eileen Reinz Peter Sehr Julia Bulkescher Karin Hoppe-Seyler Gilles Travé Felix Hoppe-Seyler

The HPV E6 oncoprotein maintains the malignant phenotype of HPV-positive cancer cells and represents an attractive therapeutic target. E6 forms a complex with the cellular E6AP ubiquitin ligase, ultimately leading to p53 degradation. The recently elucidated x-ray structure of a HPV16 E6/E6AP complex showed that HPV16 E6 forms a distinct binding pocket for E6AP. This discovery raises the questio...

Journal: :International journal of oncology 2009
Yoshiko Yamakawa-Kakuta Hitoshi Kawamata Yutaka Doi Takahiro Fujimori Yutaka Imai

Human papilloma virus (HPV) has been recently proposed to be implicated in the development of head and neck squamous cell carcinoma (HNSCC) in patients without cancer risk. We examined the expression of HPV16/18 E6/E7 in 71 cases of HNSCCs and investigated abnormalities of the p53 gene in 62 of these 71 cases. Expression of HPV16 E6/E7 was observed in 11 of the 71 cases (15.5%), while expressio...

2013
Laurel D. Lorenz Jessenia Rivera Cardona Paul F. Lambert

The human papillomavirus DNA genome undergoes three distinct stages of replication: establishment, maintenance and amplification. We show that the HPV16 E6 protein is required for the maintenance of the HPV16 DNA genome as an extrachromosomal, nuclear plasmid in its natural host cell, the human keratinocyte. Based upon mutational analyses, inactivation of p53 by E6, but not necessarily E6-media...

Journal: :Journal of immunology 2001
M Evans L K Borysiewicz A S Evans M Rowe M Jones U Gileadi V Cerundolo S Man

Human papillomavirus (HPV) infection, particularly type 16, is causally associated with the development of cervical cancer. The E6 and E7 proteins of HPV are constitutively expressed in cervical carcinoma cells making them attractive targets for CTL-based immunotherapy. However, few studies have addressed whether cervical carcinomas can process and present HPV E6/E7-derived Ags for recognition ...

2012
Juan Pablo Muñoz Carolina González Bárbara Parra Alejandro H. Corvalán Maria Lina Tornesello Yoshito Eizuru Francisco Aguayo

The smoking habit is the most important, but not a sufficient cause for lung cancer development. Several studies have reported the human papillomavirus type 16 (HPV16) presence and E6 and E7 transcripts expression in lung carcinoma cases from different geographical regions. The possible interaction between HPV infection and smoke carcinogens, however, remains unclear. In this study we address a...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید